[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Readmission in Patients with Chronic Kidney Disease undergoing PCI",
    "section": "",
    "text": "Reference Studies:\n\nNowrouzi et al., 2022\n\nStudy Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults patients undergoing percutaneous coronary intervention and has been diagnosed with chronic kidney disease, using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its association with in-hospital mortality.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nPatients aged ≥ 18 years\nUndergoing percutaneous coronary intervention as the primary procedure.\nPrimary or secondary diagnosis of chronic kidney disease.\n\nCKD was categorized as following:\n\nNo CKD\nCKD Stage 1-3\nCKD Stage 3-4\nESRD\n\n\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid injury-related returns\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nAll-cause 30-day readmission\n\nSecondary Outcomes (index admission):\n\nIn-hospital mortality (DIED)\nLength of stay (LOS, in days)\nTotal hospitalization charges (TOTCHG), inflation-adjusted to 2017 USD\nDischarge disposition\n\nReadmission Characteristics:\n\nIn-hospital mortality\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using HCUP NRD’s methodology. Readmissions were identified only among patients with qualifying index events.\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid unrelated admissions.\n\nMortality:\n\nIn-hospital death recorded during index or readmission (DIED = 1)\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCharge:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\nDischarge Disposition:\n-   Home/self-care\n\n-   Transfer to another short-term hospital\n\n-   Transfer to skilled nursing facility (SNF), intermediate, or other facility\n-   Left against medical advice\n\n-   Died in hospital\n\n-   Alive, destination unknown\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nAge (continuous)\nSex (FEMALE; ref = Male)\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nIncome quartile based on ZIP code (ZIPINC_QRTL)\n\nComorbidities and Clinical Covariates:\n\nDiabetes\nHypertension\nCongestive heart failure\nChronic pulmonary disease\nAnemia\nLiver disease\nObesity\nRenal Failure\nCardiac Arrhythmia\nHistory of undergoing PCI\nHistory of undergoing CABG\nHistory of myocardial infarction\nPeripheral vascular disease\nPulmonary Circulation Disorders\nValvular disease\nHypothyroidism\nAtrial fibrillation\nHyperlipidemia\nDepression\nFluid and electrolyte imbalance\nCerebrovascular disease\nCoagulopathy\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nDischarge disposition\nLength of stay\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses accounted for NRD’s complex survey design using weights (DISCWT), strata (NRD_STRATUM), and clustering (HOSP_NRD). Survey-adjusted methods were implemented via survey and srvyr packages.\n\nDescriptive Analyses:\n\nBaseline characteristics were summarized across stage of CKD using survey-weighted means/proportions.\nP-values from design-based statistical tests (Rao–Scott adjusted chi-square for categorical variables; design-based Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\nReadmission Characteristics:\n\nA sub-analysis among patients with 30-day readmissions summarized readmission hospitalization characteristics descriptively using weighted survey statistics.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Readmission in Patients with Chronic Kidney Disease undergoing PCI",
    "section": "",
    "text": "Reference Studies:\n\nNowrouzi et al., 2022\n\nStudy Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults patients undergoing percutaneous coronary intervention and has been diagnosed with chronic kidney disease, using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its association with in-hospital mortality.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nPatients aged ≥ 18 years\nUndergoing percutaneous coronary intervention as the primary procedure.\nPrimary or secondary diagnosis of chronic kidney disease.\n\nCKD was categorized as following:\n\nNo CKD\nCKD Stage 1-3\nCKD Stage 3-4\nESRD\n\n\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid injury-related returns\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nAll-cause 30-day readmission\n\nSecondary Outcomes (index admission):\n\nIn-hospital mortality (DIED)\nLength of stay (LOS, in days)\nTotal hospitalization charges (TOTCHG), inflation-adjusted to 2017 USD\nDischarge disposition\n\nReadmission Characteristics:\n\nIn-hospital mortality\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using HCUP NRD’s methodology. Readmissions were identified only among patients with qualifying index events.\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid unrelated admissions.\n\nMortality:\n\nIn-hospital death recorded during index or readmission (DIED = 1)\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCharge:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\nDischarge Disposition:\n-   Home/self-care\n\n-   Transfer to another short-term hospital\n\n-   Transfer to skilled nursing facility (SNF), intermediate, or other facility\n-   Left against medical advice\n\n-   Died in hospital\n\n-   Alive, destination unknown\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nAge (continuous)\nSex (FEMALE; ref = Male)\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nIncome quartile based on ZIP code (ZIPINC_QRTL)\n\nComorbidities and Clinical Covariates:\n\nDiabetes\nHypertension\nCongestive heart failure\nChronic pulmonary disease\nAnemia\nLiver disease\nObesity\nRenal Failure\nCardiac Arrhythmia\nHistory of undergoing PCI\nHistory of undergoing CABG\nHistory of myocardial infarction\nPeripheral vascular disease\nPulmonary Circulation Disorders\nValvular disease\nHypothyroidism\nAtrial fibrillation\nHyperlipidemia\nDepression\nFluid and electrolyte imbalance\nCerebrovascular disease\nCoagulopathy\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nDischarge disposition\nLength of stay\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses accounted for NRD’s complex survey design using weights (DISCWT), strata (NRD_STRATUM), and clustering (HOSP_NRD). Survey-adjusted methods were implemented via survey and srvyr packages.\n\nDescriptive Analyses:\n\nBaseline characteristics were summarized across stage of CKD using survey-weighted means/proportions.\nP-values from design-based statistical tests (Rao–Scott adjusted chi-square for categorical variables; design-based Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nA survey-weighted logistic regression modeled predictors of 30-day readmission.\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nResults were exponentiated to yield odds ratios (ORs) with 95% confidence intervals.\n\nReadmission Characteristics:\n\nA sub-analysis among patients with 30-day readmissions summarized readmission hospitalization characteristics descriptively using weighted survey statistics.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#descriptive-analyses",
    "href": "quarto/index.html#descriptive-analyses",
    "title": "Readmission in Patients with Chronic Kidney Disease undergoing PCI",
    "section": "Descriptive Analyses",
    "text": "Descriptive Analyses\n\nBaseline Characteristics\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 804,0361\nNo CKD\nN = 682,9971\nCKD, Stage 1-3\nN = 78,0191\nCKD, Stage 4-5\nN = 14,7231\nESRD\nN = 28,2971\np-value2\n\n\n\n\nAge (years)\n65 (12)\n64 (12)\n72 (11)\n72 (11)\n65 (12)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Male\n540,231 (67%)\n463,621 (68%)\n51,198 (66%)\n8,576 (58%)\n16,836 (59%)\n\n\n\n\n    Female\n263,805 (33%)\n219,376 (32%)\n26,821 (34%)\n6,147 (42%)\n11,461 (41%)\n\n\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n230,007 (29%)\n215,191 (32%)\n10,615 (14%)\n1,670 (11%)\n2,531 (9.0%)\n\n\n\n\n    Medicaid\n73,414 (9.1%)\n66,260 (9.7%)\n4,252 (5.5%)\n905 (6.2%)\n1,997 (7.1%)\n\n\n\n\n    Medicare\n434,480 (54%)\n339,835 (50%)\n59,960 (77%)\n11,686 (79%)\n22,998 (81%)\n\n\n\n\n    Other\n65,003 (8.1%)\n60,692 (8.9%)\n3,131 (4.0%)\n451 (3.1%)\n729 (2.6%)\n\n\n\n\nMedian Household Income Quartile\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    0-25th percentile\n236,911 (30%)\n199,245 (30%)\n23,023 (30%)\n4,412 (30%)\n10,232 (37%)\n\n\n\n\n    26th to 50th percentile\n222,803 (28%)\n189,621 (28%)\n21,498 (28%)\n4,170 (29%)\n7,514 (27%)\n\n\n\n\n    51st to 75th percentile\n192,904 (24%)\n164,295 (24%)\n19,095 (25%)\n3,468 (24%)\n6,046 (22%)\n\n\n\n\n    76th to 100th percentile\n139,084 (18%)\n119,180 (18%)\n13,350 (17%)\n2,490 (17%)\n4,065 (15%)\n\n\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Small\n87,706 (11%)\n75,002 (11%)\n8,841 (11%)\n1,378 (9.4%)\n2,484 (8.8%)\n\n\n\n\n    Large\n492,853 (61%)\n418,172 (61%)\n47,211 (61%)\n9,115 (62%)\n18,355 (65%)\n\n\n\n\n    Medium\n223,478 (28%)\n189,823 (28%)\n21,967 (28%)\n4,230 (29%)\n7,458 (26%)\n\n\n\n\nHospital Location and Teaching Status\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Metropolitan, non-teaching\n201,618 (25%)\n173,771 (25%)\n18,165 (23%)\n3,419 (23%)\n6,262 (22%)\n\n\n\n\n    Metropolitan, teaching\n558,083 (69%)\n470,765 (69%)\n55,708 (71%)\n10,609 (72%)\n21,002 (74%)\n\n\n\n\n    Non-metropolitan\n44,335 (5.5%)\n38,461 (5.6%)\n4,146 (5.3%)\n695 (4.7%)\n1,033 (3.7%)\n\n\n\n\nNon home discharge\n82,002 (10%)\n58,285 (8.5%)\n13,482 (17%)\n3,427 (23%)\n6,807 (24%)\n&lt;0.001\n\n\nNumber of comorbidities\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    No comorbidities\n37,691 (4.7%)\n37,691 (5.5%)\n0 (0%)\n0 (0%)\n0 (0%)\n\n\n\n\n    One comorbidity\n230,204 (29%)\n230,204 (34%)\n0 (0%)\n0 (0%)\n0 (0%)\n\n\n\n\n    Two or more comorbidities\n536,141 (67%)\n415,102 (61%)\n78,019 (100%)\n14,723 (100%)\n28,297 (100%)\n\n\n\n\nCongestive heart failure\n284,612 (35%)\n210,196 (31%)\n44,745 (57%)\n10,332 (70%)\n19,340 (68%)\n&lt;0.001\n\n\nChronic pulmonary disease\n159,926 (20%)\n128,406 (19%)\n20,759 (27%)\n3,922 (27%)\n6,839 (24%)\n&lt;0.001\n\n\nLiver disease\n25,532 (3.2%)\n19,980 (2.9%)\n3,195 (4.1%)\n620 (4.2%)\n1,737 (6.1%)\n&lt;0.001\n\n\nObesity\n163,777 (20%)\n134,748 (20%)\n19,540 (25%)\n3,603 (24%)\n5,885 (21%)\n&lt;0.001\n\n\nHypertension\n649,653 (81%)\n534,045 (78%)\n73,936 (95%)\n14,083 (96%)\n27,590 (98%)\n&lt;0.001\n\n\nDiabetes\n321,166 (40%)\n243,780 (36%)\n46,049 (59%)\n9,959 (68%)\n21,378 (76%)\n&lt;0.001\n\n\nAnemia\n130,095 (16%)\n75,960 (11%)\n24,911 (32%)\n8,031 (55%)\n21,193 (75%)\n&lt;0.001\n\n\nPrevious PCI\n167,395 (21%)\n136,249 (20%)\n20,396 (26%)\n3,601 (24%)\n7,148 (25%)\n&lt;0.001\n\n\nPrevious CABG\n80,421 (10%)\n60,780 (8.9%)\n13,011 (17%)\n2,335 (16%)\n4,296 (15%)\n&lt;0.001\n\n\nPrior myocardial infarction\n144,603 (18%)\n116,840 (17%)\n17,876 (23%)\n3,438 (23%)\n6,449 (23%)\n&lt;0.001\n\n\nPeripheral vascular disease\n102,449 (13%)\n74,228 (11%)\n17,781 (23%)\n3,502 (24%)\n6,938 (25%)\n&lt;0.001\n\n\nPulmonary circulation disorders\n39,752 (4.9%)\n25,735 (3.8%)\n8,090 (10%)\n1,890 (13%)\n4,038 (14%)\n&lt;0.001\n\n\nValvular disease\n99,613 (12%)\n73,980 (11%)\n16,293 (21%)\n3,250 (22%)\n6,089 (22%)\n&lt;0.001\n\n\nHypothyroidism\n88,348 (11%)\n68,581 (10%)\n12,977 (17%)\n2,632 (18%)\n4,158 (15%)\n&lt;0.001\n\n\nAtrial fibrillation\n127,506 (16%)\n95,637 (14%)\n20,701 (27%)\n4,035 (27%)\n7,132 (25%)\n&lt;0.001\n\n\nHyperlipidemia\n579,131 (72%)\n489,433 (72%)\n60,364 (77%)\n10,720 (73%)\n18,614 (66%)\n&lt;0.001\n\n\nDepression\n73,045 (9.1%)\n59,199 (8.7%)\n9,103 (12%)\n1,517 (10%)\n3,226 (11%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n157,087 (20%)\n113,045 (17%)\n23,672 (30%)\n6,632 (45%)\n13,738 (49%)\n&lt;0.001\n\n\nCerebrovascular disease\n41,356 (5.1%)\n30,635 (4.5%)\n6,952 (8.9%)\n1,318 (9.0%)\n2,451 (8.7%)\n&lt;0.001\n\n\nCoagulopathy\n36,344 (4.5%)\n25,791 (3.8%)\n5,817 (7.5%)\n1,340 (9.1%)\n3,396 (12%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment; NA\n\n\n\n\n\n\n\n\n\n\nOutcomes of Index Hospitalizations\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 804,0361\nNo CKD\nN = 682,9971\nCKD, Stage 1-3\nN = 78,0191\nCKD, Stage 4-5\nN = 14,7231\nESRD\nN = 28,2971\np-value2\n\n\n\n\n30-Day Readmission\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Without Readmission\n731,409 (91%)\n629,737 (92%)\n67,236 (86%)\n12,049 (82%)\n22,386 (79%)\n\n\n\n\n    With 30-day readmission\n72,628 (9.0%)\n53,261 (7.8%)\n10,783 (14%)\n2,673 (18%)\n5,911 (21%)\n\n\n\n\nIn-Hospital Mortality\n24,239 (3.0%)\n18,149 (2.7%)\n3,044 (3.9%)\n1,015 (6.9%)\n2,030 (7.2%)\n&lt;0.001\n\n\nLength of Stay (days)\n3.0 (2.0, 4.0)\n2.0 (2.0, 4.0)\n4.0 (2.0, 7.0)\n6.0 (3.0, 11.0)\n5.0 (3.0, 10.0)\n&lt;0.001\n\n\nInflation-Adjusted Total Charges ($)\n83,436 (57,922, 128,109)\n80,842 (56,621, 122,424)\n95,374 (64,059, 151,818)\n110,485 (71,785, 182,095)\n122,740 (78,908, 202,320)\n&lt;0.001\n\n\nDischarged to Non-Home Setting\n82,002 (10%)\n58,285 (8.5%)\n13,482 (17%)\n3,427 (23%)\n6,807 (24%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#readmission-hospitalization-characteristics",
    "href": "quarto/index.html#readmission-hospitalization-characteristics",
    "title": "Readmission in Patients with Chronic Kidney Disease undergoing PCI",
    "section": "Readmission Hospitalization Characteristics",
    "text": "Readmission Hospitalization Characteristics\n\nReadmission Rate:\nIndex hospitalizations resulted in:\n\nReadmission (n): 72627\nReadmission Rate (%): 9.03%\nReadmission Rate (95% CI): 8.89% to 9.18%\n\n\n\nIn-Hospital Mortality by Readmission Status:\n\n\nIn-Hospital Mortality Among Readmitted Patients\nReadmission hospitalizations resulted in:\n\nDeaths (n): 2393\nDeath Rate (%): 3.28%\nDeath Rate (95% CI): 3.08% to 3.48%\n\n\n\nResource Utilization During Readmission\nReadmission hospitalizations resulted in:\n\nMedian Length of Stay (IQR), days: 3 (IQR: 2–5)\nMedian Total Charges (IQR): $33,446 (IQR: $17,758–$65,489)"
  },
  {
    "objectID": "quarto/index.html#multivariable-analyses",
    "href": "quarto/index.html#multivariable-analyses",
    "title": "Readmission in Patients with Chronic Kidney Disease undergoing PCI",
    "section": "Multivariable Analyses",
    "text": "Multivariable Analyses\n\n30-Day Readmission:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nCKD Stage\n\n\n\n\n\n\n\n\n    No CKD\n—\n—\n\n\n\n\n    CKD, Stage 1-3\n1.22\n1.18, 1.27\n&lt;0.001\n\n\n    CKD, Stage 4-5\n1.44\n1.34, 1.54\n&lt;0.001\n\n\n    ESRD\n1.63\n1.55, 1.72\n&lt;0.001\n\n\nAge (years)\n1.00\n1.00, 1.01\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n1.16\n1.13, 1.19\n&lt;0.001\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.63\n1.55, 1.72\n&lt;0.001\n\n\n    Medicare\n1.45\n1.39, 1.51\n&lt;0.001\n\n\n    Other\n1.18\n1.11, 1.25\n&lt;0.001\n\n\nMedian Household Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n0.93\n0.89, 0.96\n&lt;0.001\n\n\n    51st to 75th percentile\n0.92\n0.89, 0.96\n&lt;0.001\n\n\n    76th to 100th percentile\n0.87\n0.83, 0.91\n&lt;0.001\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n1.02\n0.96, 1.07\n0.6\n\n\n    Medium\n1.03\n0.97, 1.09\n0.3\n\n\nHospital Location and Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n0.96\n0.93, 1.00\n0.041\n\n\n    Non-metropolitan\n0.89\n0.82, 0.97\n0.006\n\n\nNon home discharge\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.87, 0.95\n&lt;0.001\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.54\n1.50, 1.58\n&lt;0.001\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n1.30, 1.37\n&lt;0.001\n\n\nLiver_disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n0.99, 1.13\n0.090\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.90, 0.95\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.15\n1.10, 1.19\n&lt;0.001\n\n\nDiabetes\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.25\n1.21, 1.28\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.32\n1.28, 1.36\n&lt;0.001\n\n\nPrevious PCI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n1.00, 1.07\n0.042\n\n\nPrevious CABG\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.01, 1.09\n0.010\n\n\nPrior myocardial infarction\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.93, 0.99\n0.015\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.20\n1.16, 1.24\n&lt;0.001\n\n\nPulmonary Circulation Disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n1.01, 1.12\n0.012\n\n\nValvular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n1.13, 1.20\n&lt;0.001\n\n\nHypothyroidism\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.01, 1.09\n0.011\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.29\n1.25, 1.33\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.87, 0.92\n&lt;0.001\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n1.19, 1.29\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n1.11, 1.18\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.20\n1.15, 1.26\n&lt;0.001\n\n\nCoagulopathy\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.89, 1.00\n0.045\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  }
]